Edwards Lifesciences Net Profit Margin 2012-2025 | EW
Current and historical net profit margin for Edwards Lifesciences (EW) from 2012 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue. Edwards Lifesciences net profit margin for the three months ending December 31, 2025 was .
| Edwards Lifesciences Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2025-12-31 | $6.07B | $1.07B | 17.68% |
| 2025-09-30 | $5.88B | $1.37B | 23.25% |
| 2025-06-30 | $5.69B | $4.15B | 72.96% |
| 2025-03-31 | $5.52B | $4.18B | 75.72% |
| 2024-12-31 | $5.44B | $4.18B | 76.76% |
| 2024-09-30 | $5.07B | $4.16B | 82.11% |
| 2024-06-30 | $4.95B | $1.47B | 29.73% |
| 2024-03-31 | $4.88B | $1.41B | 28.97% |
| 2023-12-31 | $5.01B | $1.40B | 28.00% |
| 2023-09-30 | $4.43B | $1.43B | 32.31% |
| 2023-06-30 | $4.51B | $1.39B | 30.85% |
| 2023-03-31 | $4.58B | $1.49B | 32.49% |
| 2022-12-31 | $4.46B | $1.52B | 34.09% |
| 2022-09-30 | $5.36B | $1.46B | 27.20% |
| 2022-06-30 | $5.36B | $1.46B | 27.17% |
| 2022-03-31 | $5.36B | $1.54B | 28.73% |
| 2021-12-31 | $5.23B | $1.50B | 28.72% |
| 2021-09-30 | $5.10B | $1.48B | 29.01% |
| 2021-06-30 | $4.93B | $1.46B | 29.70% |
| 2021-03-31 | $4.48B | $0.85B | 19.02% |
| 2020-12-31 | $4.39B | $0.82B | 18.78% |
| 2020-09-30 | $4.37B | $0.79B | 18.17% |
| 2020-06-30 | $4.32B | $0.74B | 17.21% |
| 2020-03-31 | $4.48B | $1.11B | 24.71% |
| 2019-12-31 | $4.35B | $1.05B | 24.08% |
| 2019-09-30 | $4.15B | $0.77B | 18.64% |
| 2019-06-30 | $3.97B | $0.73B | 18.28% |
| 2019-03-31 | $3.82B | $0.77B | 20.04% |
| 2018-12-31 | $3.72B | $0.72B | 19.41% |
| 2018-09-30 | $3.64B | $0.71B | 19.61% |
| 2018-06-30 | $3.55B | $0.66B | 18.51% |
| 2018-03-31 | $3.45B | $0.56B | 16.24% |
| 2017-12-31 | $3.44B | $0.58B | 16.96% |
| 2017-09-30 | $3.32B | $0.75B | 22.47% |
| 2017-06-30 | $3.23B | $0.72B | 22.15% |
| 2017-03-31 | $3.15B | $0.66B | 20.86% |
| 2016-12-31 | $2.96B | $0.57B | 19.24% |
| 2016-09-30 | $2.87B | $0.55B | 19.26% |
| 2016-06-30 | $2.74B | $0.53B | 19.29% |
| 2016-03-31 | $2.60B | $0.52B | 19.80% |
| 2015-12-31 | $2.49B | $0.50B | 19.85% |
| 2015-09-30 | $2.44B | $0.46B | 18.97% |
| 2015-06-30 | $2.43B | $0.44B | 18.09% |
| 2015-03-31 | $2.39B | $0.87B | 36.57% |
| 2014-12-31 | $2.32B | $0.81B | 34.93% |
| 2014-09-30 | $2.24B | $0.78B | 34.69% |
| 2014-06-30 | $2.13B | $0.76B | 35.65% |
| 2014-03-31 | $2.07B | $0.31B | 14.73% |
| 2013-12-31 | $2.05B | $0.39B | 19.01% |
| 2013-09-30 | $2.02B | $0.40B | 19.95% |
| 2013-06-30 | $1.97B | $0.40B | 20.03% |
| 2013-03-31 | $1.94B | $0.37B | 19.10% |
| 2012-12-31 | $1.90B | $0.29B | 15.32% |
| 2012-09-30 | $1.82B | $0.27B | 14.57% |
| 2012-06-30 | $1.78B | $0.25B | 13.90% |
| 2012-03-31 | $1.73B | $0.24B | 13.73% |
| 2011-12-31 | $1.68B | $0.24B | 14.12% |
| 2011-09-30 | $1.64B | $0.24B | 14.56% |
| 2011-06-30 | $1.58B | $0.24B | 14.90% |
| 2011-03-31 | $1.51B | $0.24B | 15.55% |
| 2010-12-31 | $1.45B | $0.22B | 15.13% |
| 2010-09-30 | $1.40B | $0.20B | 14.41% |
| 2010-06-30 | $1.38B | $0.23B | 16.53% |
| 2010-03-31 | $1.35B | $0.22B | 16.15% |
| 2009-12-31 | $1.32B | $0.23B | 17.46% |
| 2009-09-30 | $1.29B | $0.22B | 17.19% |
| 2009-06-30 | $1.26B | $0.18B | 14.24% |
| 2009-03-31 | $1.26B | $0.17B | 13.69% |
| 2008-12-31 | $1.24B | $0.13B | 10.41% |
| 2008-09-30 | $1.22B | $0.11B | 8.76% |
| 2008-06-30 | $1.18B | $0.10B | 8.74% |
| 2008-03-31 | $1.12B | $0.10B | 8.72% |
| 2007-12-31 | $1.09B | $0.11B | 10.36% |
| 2007-09-30 | $1.06B | $0.12B | 11.09% |
| 2007-06-30 | $1.05B | $0.12B | 11.14% |
| 2007-03-31 | $1.04B | $0.12B | 11.30% |
| 2006-12-31 | $1.04B | $0.13B | 12.63% |
| 2006-09-30 | $1.02B | $0.15B | 14.59% |
| 2006-06-30 | $1.02B | $0.12B | 11.53% |
| 2006-03-31 | $1.01B | $0.10B | 9.44% |
| 2005-12-31 | $1.00B | $0.08B | 8.02% |
| 2005-09-30 | $0.99B | $0.07B | 6.80% |
| 2005-06-30 | $0.97B | $0.08B | 8.57% |
| 2005-03-31 | $0.95B | $0.10B | 10.04% |
| 2004-12-31 | $0.93B | $0.00B | 0.21% |
| 2004-09-30 | $0.92B | $0.00B | -0.54% |
| 2004-06-30 | $0.90B | $0.01B | 0.89% |
| 2004-03-31 | $0.88B | $0.00B | 0.34% |
| 2003-12-31 | $0.86B | $0.08B | 9.29% |
| 2003-09-30 | $0.84B | $0.08B | 9.88% |
| 2003-06-30 | $0.80B | $0.04B | 5.13% |
| 2003-03-31 | $0.76B | $0.05B | 6.75% |
| 2002-12-31 | $0.70B | $0.06B | 8.10% |
| 2002-09-30 | $0.66B | $0.05B | 7.87% |
| 2002-06-30 | $0.64B | $0.08B | 13.06% |
| 2002-03-31 | $0.66B | $0.00B | -0.45% |
| 2001-12-31 | $0.69B | $-0.01B | -1.59% |
| 2001-09-30 | $0.72B | $-0.01B | -1.67% |
| 2001-06-30 | $0.76B | $-0.02B | -3.04% |
| 2001-03-31 | $0.77B | $-0.28B | -35.84% |
| 2000-12-31 | $0.80B | $-0.27B | -33.83% |
| 2000-09-30 | $0.92B | $-0.24B | -25.87% |
| 2000-06-30 | $0.93B | $-0.24B | -25.40% |
| 2000-03-31 | $0.94B | $0.09B | 9.30% |
| 1999-12-31 | $0.91B | $0.08B | 9.06% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $44.027B | $6.068B |
| Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $189.665B | 22.07 |
| Intuitive Surgical (ISRG) | United States | $172.536B | 66.55 |
| IDEXX Laboratories (IDXX) | United States | $50.254B | 48.15 |
| Alcon (ALC) | Switzerland | $39.174B | 26.40 |
| IQVIA Holdings (IQV) | United States | $28.430B | 15.36 |
| Mettler-Toledo (MTD) | United States | $27.662B | 31.81 |
| DexCom (DXCM) | United States | $26.948B | 33.50 |
| STERIS (STE) | Ireland | $24.357B | 24.64 |
| Waters (WAT) | United States | $19.256B | 24.63 |
| Coloplast (CLPBY) | Denmark | $17.511B | 26.79 |
| Hologic (HOLX) | United States | $16.752B | 17.53 |
| SONOVA HOLDING (SONVY) | Switzerland | $15.334B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $14.168B | 11.75 |
| Penumbra (PEN) | United States | $13.288B | 93.47 |
| Globus Medical (GMED) | United States | $11.790B | 24.74 |
| SARTORIUS (SSSGY) | Germany | $7.976B | 46.32 |
| Masimo (MASI) | United States | $6.991B | 22.40 |
| Glaukos (GKOS) | United States | $6.287B | 0.00 |
| Sysmex ADR (SSMXY) | Japan | $5.363B | 17.75 |
| Teleflex (TFX) | United States | $4.585B | 7.31 |
| TransMedics (TMDX) | United States | $4.437B | 52.57 |
| LivaNova (LIVN) | United Kingdom | $3.593B | 19.41 |
| Integer Holdings (ITGR) | United States | $3.011B | 14.13 |
| Veracyte (VCYT) | United States | $2.828B | 32.22 |
| Elekta AB (EKTAY) | Sweden | $2.266B | 21.19 |
| Alphatec Holdings (ATEC) | United States | $1.985B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $1.975B | 21.79 |
| UFP Technologies (UFPT) | United States | $1.896B | 25.03 |
| Artivion (AORT) | United States | $1.734B | 58.10 |
| Pulse Biosciences (PLSE) | United States | $1.559B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $1.553B | 0.00 |
| AxoGen (AXGN) | United States | $1.533B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.285B | 0.00 |
| IRadimed (IRMD) | United States | $1.270B | 57.03 |
| OPKO Health (OPK) | United States | $0.944B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.882B | 4.78 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.692B | 13.80 |
| SiBone (SIBN) | United States | $0.665B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.614B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.612B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.591B | 34.35 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.530B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.516B | 0.00 |
| NeuroPace (NPCE) | United States | $0.501B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.500B | 13.03 |
| AngioDynamics (ANGO) | United States | $0.452B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.424B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.385B | 0.00 |
| RxSight (RXST) | United States | $0.331B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.329B | 54.76 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Sight Sciences (SGHT) | United States | $0.283B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.281B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.235B | 0.00 |
| 908 Devices (MASS) | United States | $0.235B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.183B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.175B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.173B | 0.00 |
| Inogen (INGN) | United States | $0.156B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.149B | 0.00 |
| LENSAR (LNSR) | United States | $0.146B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.146B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.132B | 0.00 |
| CVRx (CVRX) | United States | $0.130B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.119B | 0.00 |
| Hyperfine (HYPR) | United States | $0.108B | 0.00 |
| Neuronetics (STIM) | United States | $0.097B | 0.00 |
| Solana (HSDT) | United States | $0.091B | 0.00 |
| DarioHealth (DRIO) | United States | $0.079B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.078B | 0.00 |
| InspireMD (NSPR) | United States | $0.074B | 0.00 |
| Positron (POSC) | United States | $0.067B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.067B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.063B | 0.00 |
| Accuray (ARAY) | United States | $0.062B | 0.00 |
| Spectral AI (MDAI) | United States | $0.048B | 0.00 |
| Precision Optics (POCI) | United States | $0.037B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.036B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.026B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.021B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.020B | 0.00 | |
| Envoy Medical (COCH) | United States | $0.017B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.013B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.012B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.011B | 0.00 |
| NexGel (NXGL) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.006B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| ENvue Medical (FEED) | United States | $0.003B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |